0001493152-21-017774.txt : 20210826 0001493152-21-017774.hdr.sgml : 20210826 20210726165828 ACCESSION NUMBER: 0001493152-21-017774 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210726 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OncoCyte Corp CENTRAL INDEX KEY: 0001642380 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 271041563 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 15 CUSHING CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-409-7600 MAIL ADDRESS: STREET 1: 15 CUSHING CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: Oncocyte Corp DATE OF NAME CHANGE: 20200205 FORMER COMPANY: FORMER CONFORMED NAME: OncoCyte Corp DATE OF NAME CHANGE: 20150513 CORRESP 1 filename1.htm

Oncocyte Corporation

15 Cushing

Irvine, California 92618

July 26, 2021

VIA EDGAR

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Chris Edwards

Re:	Oncocyte Corporation
	Registration Statement on Form S-3
	File No. 333-257905

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Oncocyte Corporation (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Thursday, July 29, 2021, or as soon thereafter as possible.

Please notify Kandace Watson of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (858) 720-8930 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

	ONCOCYTE CORPORATION

	By:	/s/ Mitchell Levine
	Name:	Mitchell Levine
	Title:	Chief Financial Officer

- 1 -